beta
RXII
RXi Pharmaceuticals Corporation
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
RXi Pharmaceuticals Corp is a clinical-stage RNAi company developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which address significant unmet medical needs.
Market Cap: 972 Thousand
Primary Exchange: NASDAQ Capital Market
Website: http://www.rxipharma.com
Shares Outstanding: 237 Thousand
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.913749
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1856 trading days
From: 2014-02-24 To: 2018-11-16
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2016-04-18 | 10.0 | 1.0 | 10.0 | |||
| 2018-01-08 | 10.0 | 1.0 | 10.0 |